Department of Psychiatry, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Psychooncology. 2012 Dec;21(12):1331-7. doi: 10.1002/pon.2075. Epub 2011 Oct 9.
Our objective is to measure the prevalence and correlates of major depressive disorder (MDD) among Chinese breast cancer patients after surgery, which is essential for analyzing the service needs and allocating mental health resources.
A total of 505 patients were randomly recruited from 1580 post-surgery breast cancer outpatients from one tertiary hospital in Shanghai, and the Mini International Neuropsychiatric Interview was used to assess 1-month prevalence of MDD according to the Diagnostic and Statistical Manual Fourth Edition (DSM-IV) in a two-phase design.
The adjusted 1-month prevalence of MDD was 20.59% (95% CI 17.06-23.82). The risk for depression within the first year was two times as higher as that in more than 1 year. Patients within 1 year after surgery, with lower income, disrupted marriage or being single, recurrent breast cancer and psychiatric history were more likely to have MDD. There was no significant association between depression and disease stage, type of surgery, receptor status and cancer treatment.
Depression is quite common in Chinese breast cancer patients and survivors. A more sensitive and responsive mental health service is recommended for this population.
本研究旨在测量中国乳腺癌术后患者中重度抑郁障碍(MDD)的患病率及其相关因素,这对于分析服务需求和分配精神卫生资源至关重要。
采用两阶段设计,从上海一家三级医院的 1580 名术后乳腺癌门诊患者中随机招募了 505 名患者,使用 Mini 国际神经精神访谈,根据《精神障碍诊断与统计手册第四版》(DSM-IV)评估 MDD 的 1 个月患病率。
调整后的 1 个月 MDD 患病率为 20.59%(95%CI 17.06-23.82)。术后 1 年内发生抑郁的风险是 1 年以上的两倍。术后 1 年内、收入较低、婚姻破裂或单身、乳腺癌复发和有精神病史的患者更有可能患有 MDD。抑郁与疾病分期、手术类型、受体状态和癌症治疗之间无显著关联。
中国乳腺癌患者和幸存者中抑郁较为常见。建议为这一人群提供更敏感和响应性的精神卫生服务。